Adjuvant therapy with flutamide for presurgical volume reduction in juvenile nasopharyngeal angiofibroma

Abstract

Prepubertal and postpubertal patients differ in their response to flutamide. In postpubertal patients, 6 weeks preoperative use is safe and leads to partial tumor regression. Tumor regression from adjacent vital structures may facilitate surgical excision and limit morbidity.